HeartBeam(NASDAQ) BEATW

Market CapN/A

Since IPO (2021)-98%

5 YearN/A

1 Year-93%

1 Month-23%

$0.03

+0.61%

+0.00Today

HeartBeam last closing stock price
Metric	Price	Date
Last close	USD 0.02	2026-07-27

HeartBeam stock price return by period
Period	Price return	Price at period start	Period start date
1 week	-35.98%	USD 0.03	2026-07-20
1 month	-22.51%	USD 0.03	2026-06-26
3 month	-78.32%	USD 0.10	2026-04-24
Year to date	-93.44%	USD 0.32	2025-12-31
1 year	-92.94%	USD 0.30	2025-07-25
3 year	-95.67%	USD 0.49	2023-07-28
Since inception	-97.56%	USD 0.86	2021-11-11

HeartBeam Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$0.00

Net Income (TTM)

-$20.23M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.03

Volume

8,572

Open

$0.02

Price

$0.03

Volume

8,572

Open

$0.02

Previous Close

$0.02

Daily Range

$0.02 - $0.02

52-Week Range

$0.02 - $0.56

Estimated Earnings Date

Aug 6, 2026

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.03

Volume

8,572

Open

$0.02

Previous Close

$0.02

Daily Range

$0.02 - $0.02

52-Week Range

$0.02 - $0.56

Estimated Earnings Date

Aug 6, 2026

BEATW News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About HeartBeam

HeartBeam, Inc. is an innovative company focused on developing advanced cardiovascular diagnostic technology. The company has created a unique electrocardiogram (ECG) device that allows for remote monitoring of heart health, enabling healthcare professionals to access critical data outside traditional clinical settings.

Products and Services

Remote ECG collection device for heart health monitoring
Cloud-based software for real-time data analysis
Innovative solutions aimed at improving cardiovascular diagnostics

Growth Outlook

Significant market potential in remote healthcare diagnostics
Increasing demand for telehealth solutions post-pandemic
Strategic partnerships may enhance product reach and development

Financial Highlights

Recent quarterly net income of -$4.7 million, reflecting ongoing investment in R&D
Cash and short-term investments totaled $2.04 million as of March 31, 2026
Operating expenses of $4.69 million in the latest quarter, indicating a focus on growth

HeartBeam, Inc. operates in the healthcare sector, specifically within medical technology, and is headquartered in Santa Clara, California. The company aims to revolutionize cardiovascular care through its innovative ECG technology, which allows for remote patient monitoring. This capability is increasingly relevant in today's healthcare landscape, where telehealth solutions are gaining traction. The growth outlook for HeartBeam is promising, driven by the rising demand for remote healthcare solutions and the potential for strategic partnerships that could expand its market presence. Financially, the company is currently in a phase of significant investment, as evidenced by its recent net income figures and operating expenses. While the company has yet to achieve profitability, the focus on research and development positions it well for future growth in a rapidly evolving market. Investors may find HeartBeam's commitment to innovation and its strategic positioning within the healthcare technology sector noteworthy as the company continues to develop its product offerings and expand its market reach.

AI Generated • Jul 24, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Headquarters

Santa Clara, CA 95050, US

BEATW Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

-1034.04%

Return on Capital

-812.10%

Return on Assets

-514.91%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

Volume

8.57K

Avg. Volume

7.14K

Financials (TTM)

Gross Profit

-$24.00K

Operating Income

-$20.35M

EBITDA

-$20.17M

Operating Cash Flow

-$13.12M

Capital Expenditure

-$846.00K

Free Cash Flow

-$13.97M

Cash & ST Invst.

$2.04M

Total Debt

$0.00

HeartBeam Performance Analysis

HeartBeam sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q2	2025-06-30	N/A
Q3	2025-09-30	N/A
Q4	2025-12-31	N/A
Q1	2026-03-31	N/A

HeartBeam sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q2	2025-06-30	16.7%
Q3	2025-09-30	N/A
Q4	2025-12-31	N/A
Q1	2026-03-31	20.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$24.00K

N/A

Gross Margin

0.00%

N/A

Market Cap

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

-$4.70M

+14.3%

EBITDA

-$4.68M

+14.6%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$2.04M

-75.0%

Total Debt

$0.00

N/A

Accounts Receivable

$0.00

N/A

Inventory

$133.00K

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-5.15%

N/A

Return on Invested Capital

-32.05%

N/A

Free Cash Flow

-$3.86M

+13.9%

Operating Cash Flow

-$3.61M

+19.4%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

KZRKezar Life Sciences, Inc.

KZRKezar Life Sciences, Inc.$7.29+0.00%

FGENFibroGen, Inc.

FGENFibroGen, Inc.$9.07-1.63%

NOTVInotiv, Inc.

NOTVInotiv, Inc.$0.08+121.94%

TPSTTempest Therapeutics, Inc.

TPSTTempest Therapeutics, Inc.$0.93+0.94%

RNTXRein Therapeutics Inc.

RNTXRein Therapeutics Inc.$0.78-1.23%

OKUROnKure Therapeutics, Inc.

OKUROnKure Therapeutics, Inc.$4.05-1.70%

ALGSAligos Therapeutics, Inc.

ALGSAligos Therapeutics, Inc.$4.08+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.25+0.10%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$7.24-0.02%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$63.40-0.01%

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$113.50-0.01%

RIGTransocean

RIGTransocean$5.28-0.01%

PATHUiPath

PATHUiPath$11.62+0.07%

JOBYJoby Aviation

JOBYJoby Aviation$7.37+0.06%

Questions About BEATW

What is the current price of HeartBeam?

HeartBeam is trading at $0.02 per share.

What is the 52-week range for HeartBeam?

Over the past 52 weeks, HeartBeam has traded between $0.02 and $0.56.

How much debt does HeartBeam have?

HeartBeam total debt is unavailable.

How much cash does HeartBeam have on hand?

HeartBeam does not have cash on hand data available.

What is HeartBeam’s dividend yield?

HeartBeam does not currently have a dividend yield.

HeartBeam(NASDAQ) BEATW

HeartBeam Financials at a Glance

BEATW News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About HeartBeam

BEATW Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

HeartBeam Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About BEATW

What is the current price of HeartBeam?

What is the 52-week range for HeartBeam?

How much debt does HeartBeam have?

How much cash does HeartBeam have on hand?

What is HeartBeam’s dividend yield?

Premium Investing Services